Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine vs Haloperidol for Prehospital Agitation
NCT02103881Phase 4Withdrawn
- Sponsor
- Hennepin Healthcare Research Institute
- Start
- Apr 2014
- Primary completion
- Jun 2014
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of ketamine in agitation, sponsored by Hennepin Healthcare Research Institute. Primary endpoint: Time from injection of drug to adequate sedation at 2 hours. Planned start Apr 2014; status: withdrawn.
02
Drugs
ketamine
03
Conditions
agitation
Beyond the preview
Go deeper on NCT02103881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02103881.